Abstracts Archive - Page 172 of 1683 - ATC Abstracts

2022 American Transplant Congress
Progression from Kidney Transplant Referral to Initiating the Pre-Transplant Evaluation: What Causes the Break Down?
T. Menser, M. J. Hobeika, E. Hsu, L. W. Moore, A. D. Waterman, A. O. Gaber, R. J. Knight
Houston Methodist, Houston, TX
*Purpose: The transplant treatment pathway is marred by both socio-economic and racial/ethnic disparities at each stage of the process, which includes conversion from referral to…
2022 American Transplant Congress
Safety and Efficacy of Peri-Vaccination Antimetabolite Hold to Augment Third SARS-CoV-2 Vaccine Dose Response in Lung Transplant Recipients
S. Frey, J. Ruck, J. Alejo, L. Barker, W. Werbel, R. Avery, D. Segev, P. Shah
Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Lung transplant recipients (LTRs) are less likely than other solid organ transplant recipients (SOTRs) to develop an antibody response to SARS-CoV-2 vaccination. Mycophenolate has…
2022 American Transplant Congress
Circumstances Influencing Likelihood to Become an Organ Donor
L. Clayton¹, K. S. Holland², C. W. Nonterah³
¹Psychology, Department of Psychology, University of Richmond, Richmond, VA, ²Psychology, Department of Psychiatry, Virginia Commonwealth University, School of Medicine, Richmond, VA, ³Department of Psychology, University of Richmond and Department of Psychiatry, Virginia Commonwealth University, School of Medicine, Richmond, VA
*Purpose: Currently, there are approximately 102,000 patients on the waitlist for a renal or liver transplant (Organ Procurement and Transplantation Network (OPTN), 2021). In 2021,…
2022 American Transplant Congress
Tacrolimus After Rabbit Antithymocyte Globulin And Infliximab Induction Immunosuppression In Kidney Transplantation
O. Viklicky¹, G. Bold², O. Bestard³, P. Hruba¹, I. Zahradka¹, N. M. Otto², M. Stein², A. Sefrin², S. Christakoudi⁴, P. M. Reinke²
¹Institute for Clinical and Experimental Medicine, Prague, Czech Republic, ²Charité, Berlin, Germany, ³Vall d'Hebron, Barcelona, Spain, ⁴King's College, London, United Kingdom
*Purpose: Selective targeting of effector/memory T cells as induction immunosuppression has been discussed in kidney transplantation. Confidence-interval-estimation study may help to estimate range of the…
2022 American Transplant Congress
Association Between CT Measurements of Body Composition Before Kidney Transplantation and Post-Transplantation Outcomes
Y. Liu, O. Shafaat, X. Chen, C. Weiss, D. Segev, M. McAdams-DeMarco
Johns Hopkins University, Baltimore, MD
*Purpose: Body composition has been found to be associated with the risks of post-kidney transplantation (KT) outcomes. However, it is unclear which pre-KT computed tomography…
2022 American Transplant Congress
Adult-to-Adult Living Donor Liver Transplantation in Acute Liver Failure – Do Outcomes Justify the Risks?
A. Shingina¹, I. A. Ziogas², P. Vutien³, E. Uleryk⁴, E. Renner⁵, M. P. Bhat⁶, J. Tinmouth⁴, J. Kim⁷
¹Vanderbilt University, Nashville, TN, ²Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, ³University of Washington Medical Center, Seattle, WA, ⁴University of Toronto, Toronto, ON, Canada, ⁵University of Manitoba, Saskatchewan, MB, Canada, ⁶Multi-Organ Transplant, UHN, Toronto, ON, Canada, ⁷Toronto General Hospital, Toronto, ON, Canada
*Purpose: Living-donor Liver Transplantation(LDLT) has emerged as a safe and effective alternative in children and adults with pre-existing liver diseases. Utilization of LDLT for patients…
2022 American Transplant Congress
Causal Factors and Clinical Impact of Urinary Tract Infections in Renal Transplanted Patients: An Observational Retrospective Study
C. Alfieri, F. Tripodi, D. Cresseri, M. Gandolfo, M. Campise, A. Regalia, P. Messa, G. Castellano
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico Milano, Milan, Italy
*Purpose: This study aims to examine the etiology of urinary tract infections (UTIs) in a cohort of KTxps, trying to identify their potential predisposing factors…
2022 American Transplant Congress
Impact of Cold Ischemia Times on 1 Year Kidney Transplant Outcomes
T. Fletchinger, L. Burdine
Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, AR
*Purpose: Recent organ allocation changes have increased travel and subsequent cold ischemia times (CIT) of kidney allografts. We sought to investigate the impact of prolonged…
2022 American Transplant Congress
Stem Cell Donor-Derived CPRA Better Reflects Sensitization Than Current CPRA
K. Lindblad¹, C. Murphey², P. Lalli³, J. Lunz⁴, L. Gragert⁵
¹UNOS, Richmnd, VA, ²Southwest Immunodiagnostics, Inc., San Antonio, TX, ³Carolinas Medical Center, Charlotte, NC, ⁴LifeLink Foundation Transplant Immunology Lab, Tampa, FL, ⁵Tulane University School of Medicine, New Orleans, LA
*Purpose: The OPTN Histocompatibility Committee proposes replacing the current calculated panel reactive antibody (CPRA), based on HLA haplotype frequencies from ~14,000 deceased kidney donors, with…
2022 American Transplant Congress
Outcomes of Living Donor Liver Transplant Using Low Graft Recipient Weight Ratio (GRWR ≤ 0.8)
V. Gunabushanam, S. Ganesh, A. Tevar, A. Ganoza, M. Molinari, C. Hughes, A. Humar
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Low Graft recipient ratio (≤ 0.8) in adult living donor liver transplantation is considered a major risk factor affecting patient and graft survival. The…